-
Product Insights
Charcot-Marie-Tooth Disease Type II – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type II - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type II pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type II, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Rett Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Rett Syndrome - Drugs In Development, 2023’, provides an overview of the Rett Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rett Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Charcot-Marie-Tooth Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Spinal Muscular Atrophy (SMA) – Drugs In Development, 2023
Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Drugs In Development, 2023’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Spinal Muscular Atrophy (SMA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Neurovascular Accessory Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurovascular Accessory Devices Pipeline Market Overview Neurovascular accessories are devices used during neurovascular procedures to aid in the introduction of treatment devices or provide further support during the procedure. Accessories included are microguidewires, microcatheters, and distal access catheters. The Neurovascular Accessory Devices pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·      Microcatheters ·      ...
-
Product Insights
Neurosurgical Products Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurosurgical Products Pipeline Market Report Overview The neurosurgical products pipeline market research report provides comprehensive information about the neurosurgical products pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Dura Substitutes ·      Neuroendoscopes ·      Neurosurgical Drills ·      Synthetic Dura Substitutes ·      Neurosurgical Drills ·      Biological Dura Substitutes Key Territories ·      The US ·      Europe ·      Canada ·      Israel ·      Japan ·      Philippines...
-
Product Insights
Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Interventional Neuroradiology Pipeline Market Report Overview The key segments of interventional neuroradiology such as neurovascular embolization devices, neurovascular accessory devices, and neurovascular coiling assist devices are covered under in the report. The interventional neuroradiology pipeline market research report provides comprehensive information about the interventional neuroradiology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Neurovascular Accessory Devices ·      Stent Retrievers ·      Flow...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ACTX-401
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ACTX-401 Drug Details ACTX-401 is under development for the treatment of spinal muscular atrophy...
-
Product Insights
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome – Drugs In Development, 2022, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape. Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III, or the plateau and Stage IV, or the late motor deterioration stage. Symptoms include slowed growth, loss...
-
Product Insights
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Spinal muscular atrophy (SMA) pipeline market research report provides comprehensive information on the therapeutics under development for Spinal Muscular Atrophy (SMA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Spinal Muscular...